MIME CHEMOTHERAPY (METHYL-GAG, IFOSFAMIDE, METHOTREXATE, ETOPOSIDE) AS TREATMENT FOR RECURRENT HODGKINS-DISEASE

被引：122

作者：

HAGEMEISTER, FB

TANNIR, N

MCLAUGHLIN, P

SALVADOR, P

RIGGS, S

VELASQUEZ, WS

CABANILLAS, F

机构：

来源：

关键词：

D O I：

10.1200/JCO.1987.5.4.556

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：556 / 561

页数：6

共 18 条

[1] APPLEBAUM FR, 1983, J CLIN ONCOL, V1, P440
[2] ABVD CHEMOTHERAPY IN THE TREATMENT OF HODGKINS-DISEASE
BONADONNA, G
SANTORO, A
[J]. CANCER TREATMENT REVIEWS, 1982, 9 (01) : 21 - 35
[3] IFOSFAMIDE - PHARMACOLOGY, SAFETY AND THERAPEUTIC POTENTIAL
BRADE, WP
HERDRICH, K
VARINI, M
[J]. CANCER TREATMENT REVIEWS, 1985, 12 (01) : 1 - 47
[4] CABANILLAS F, 1982, BLOOD, V60, P693
[5] PROLONGED DISEASE-FREE SURVIVAL IN HODGKINS-DISEASE WITH MOPP REINDUCTION AFTER 1ST RELAPSE
FISHER, RI
DEVITA, VT
HUBBARD, SP
SIMON, R
YOUNG, RC
[J]. ANNALS OF INTERNAL MEDICINE, 1979, 90 (05) : 761 - 763
[6] GEHAN EA, 1965, BIOMETRIKA, V52, P203, DOI 10.1093/biomet/52.1-2.203
[7] JAGANNATH S, 1984, P AN M AM SOC CLIN, V3, P252
[8] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS
KAPLAN, EL
MEIER, P
[J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) : 457 - 481
[9] LIVINGSTON RB, 1970, SINGLE AGENTS CANCER
[10] PILLAI N, 1985, CANCER, V55, P691